A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years

BJU International

Volumn 112, Issue 2, 2013, Pages 169-175

  Bryan, Richard T ^a   Zeegers, Maurice P ^a,b   Van Roekel, Eline H ^a   Bird, Deborah ^c   Grant, Margaret R ^a   Dunn, Janet A ^d   Bathers, Sarah ^a   Iqbal, Gulnaz ^d   Khan, Humera S ^a   Collins, Stuart I ^c   Howman, Andrew ^c   Deshmukh, Nayneeta S ^e   James, Nicholas D ^a,e   Cheng, Kar Keung ^a   Wallace, D Michael A ^f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

bladder cancer; cohort; epidemiology; urothelial cancer

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING HABIT; TUMOR VOLUME; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84879690976     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12032     Document Type: Article

References (35)

1. Bryan RT, Wallace DM,. Have we abandoned the 'superficial' in bladder cancer? Eur Urol 2009; 56: 1091
2. Cauberg EC, de Bruin DM, Faber DJ, van, Leeuwen TG, de la, Rosette JJ, de, Reijke TM,. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 2009; 56: 287-296
3. Kaufman DS, Shipley WU, Feldman AS,. Bladder cancer. Lancet 2009; 374: 239-249
4. Wilby D, Thomas K, Ray E, Chappell B, O'Brien T,. Bladder cancer: new TUR techniques. World J Urol 2009; 27: 309-312
5. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012; 366: 1477-1488
6. Ploeg M, Aben KK, Kiemeney LA,. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293
7. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-477
8. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S,. Delay and survival in bladder cancer. BJU Int 2002; 89: 868-878
9. Zeegers MP, Bryan RT, Langford C, et al. The West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU Int 2010; 105: 784-788
10. Cooper NC, Cartwright R,. Bladder. In, Quinn M, Wood H, Cooper N, Rowan S, eds, Cancer Atlas of the United Kingdom and Ireland 1991-2000 (Office for National Statistics), Chapt. 3. Basingstoke, UK: Palgrave Macmillan, 2005: 39-50
11. Mistry M, Parkin DM, Ahmad AS, Sasieni P,. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 2011; 105: 1795-1803
12. Shah A, Rachet B, Mitry E, Cooper N, Brown CM, Coleman MP,. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008; 99 (Suppl. 1): S86-89
13. Van Hemelrijck MJ, Michaud DS, Connolly GN, Kabir Z,. Tobacco use and bladder cancer patterns in three western European countries. J Public Health (Oxf) 2009; 31: 335-344
14. Baris D, Karagas MR, Verrill C, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009; 101: 1553-1561
15. Batty GD, Kivimaki M, Gray L, Smith GD, Marmot MG, Shipley MJ,. Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann Oncol 2008; 19: 996-1002
16. Zeegers MP, Tan FE, Dorant E, van den, Brandt PA,. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-639
17. Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999; 86: 2337-2345
18. Dunstan S, Robinson S,. Smoking. In, Dunstan S, ed., General Lifestyle Survey Overview (Office for National Statistics), Chapt. 1. Newport, UK: Office for National Statistics 2012: 3-14
19. Reulen RC, Kellen E, Buntinx F, Brinkman M, Zeegers MP,. A meta-analysis on the association between bladder cancer and occupation. Scand J Urol Nephrol Suppl 2008; 218: 64-78
20. Madeb R, Messing EM,. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22: 86-92
21. Hemelt M, Yamamoto H, Cheng KK, Zeegers MP,. The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 2009; 124: 412-419
22. Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR,. Late age (85 years or older) peak incidence of bladder cancer. J Urol 2008; 179: 1302-1305
23. Smith C, Tomassini C, Smallwood S, Hawkins M,. The changing age structure of the UK population. In, Chappell R, ed., Focus On People and Migration, Chapt. 4. Basingstoke, UK: Palgrave Macmillan, Department Office for National Statistics, 2005: 61-70
24. Shipley WU, Zietman AL,. Old drugs, new purpose-bladder cancer turning a corner. N Engl J Med 2012; 366: 1540-1541
25. Froehner M, Brausi MA, Herr HW, Muto G, Studer UE,. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009; 56: 443-454
26. Harnden P,. A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change? BJU Int 2007; 99: 723-725
27. Montironi R, Lopez-Beltran A,. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005; 13: 143-153
28. Feinstein AR, Sosin DM, Wells CK,. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-1608
29. Sciarra A, De Matteis A, Mariotti G, Voria G, Lucera R, Di Silverio F,. Histopathological aspects of transitional cell carcinoma of the bladder: analysis of 20 years experience. Int J Urol 2004; 11: 467-475
30. Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F,. De novo muscle invasive bladder cancer: is there a change in trend? J Urol 2001; 165: 47-50
31. Blick C, Bailey D, Haldar N, Bdesha A, Kelleher J, Muneer A,. The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution. Ann R Coll Surg Engl 2010; 92: 46-50
32. Bryan RT, Billingham LJ, Wallace DM,. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008; 101: 702-705
33. Bryan RT, Shah ZH, Collins SI, Wallace DM,. Narrow-band imaging flexible cystoscopy: a new user's experience. J Endourol 2010; 24: 1339-1343
34. David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM,. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. Cancer 2009; 115: 1435-1447
35. Lee CT, Dunn RL, Williams C, Underwood W III,. Racial disparity in bladder cancer: trends in tumor presentation at diagnosis. J Urol 2006; 176: 927-933